Your browser doesn't support javascript.
loading
Type I interferon receptor signalling deficiency results in dysregulated innate immune responses to SARS-CoV-2 in mice.
Ogger, Patricia P; Garcia Martín, Minerva; Michalaki, Christina; Zhou, Jie; Brown, Jonathan C; Du, Yue; Miah, Kamran M; Habib, Omar; Hyde, Stephen C; Gill, Deborah R; Barclay, Wendy S; Johansson, Cecilia.
Afiliación
  • Ogger PP; Section of Respiratory Infections, National Heart and Lung Institute, Imperial College London, St Mary's Campus, London, UK.
  • Garcia Martín M; Section of Respiratory Infections, National Heart and Lung Institute, Imperial College London, St Mary's Campus, London, UK.
  • Michalaki C; Section of Respiratory Infections, National Heart and Lung Institute, Imperial College London, St Mary's Campus, London, UK.
  • Zhou J; Department of Infectious Disease, Imperial College London, St Mary's Campus, London, UK.
  • Brown JC; Department of Infectious Disease, Imperial College London, St Mary's Campus, London, UK.
  • Du Y; Radcliffe Department of Medicine (NDCLS), University of Oxford, Oxford, UK.
  • Miah KM; Radcliffe Department of Medicine (NDCLS), University of Oxford, Oxford, UK.
  • Habib O; Radcliffe Department of Medicine (NDCLS), University of Oxford, Oxford, UK.
  • Hyde SC; Radcliffe Department of Medicine (NDCLS), University of Oxford, Oxford, UK.
  • Gill DR; Radcliffe Department of Medicine (NDCLS), University of Oxford, Oxford, UK.
  • Barclay WS; Department of Infectious Disease, Imperial College London, St Mary's Campus, London, UK.
  • Johansson C; Section of Respiratory Infections, National Heart and Lung Institute, Imperial College London, St Mary's Campus, London, UK.
Eur J Immunol ; 52(11): 1768-1775, 2022 11.
Article en En | MEDLINE | ID: mdl-36106692

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptor de Interferón alfa y beta / COVID-19 / Inmunidad Innata Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptor de Interferón alfa y beta / COVID-19 / Inmunidad Innata Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Año: 2022 Tipo del documento: Article